Global Animal Health Market Segmented By Type (Production Animal, Poultry, Swine, Cattle, Sheep & Goats, Fish, Companion Animal, Dogs, Cats, Horses) By Product (Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Inactivated Vaccines, Pharmaceuticals, Parasiticides, Anti-infectives, Anti-inflammatory, Analgesics, Feed Additives, Nutritional, Medicinal, Diagnostics, Instruments, Consumables) By Distribution Channel (Retail, E-commerce, Veterinary Hospitals & Clinics) By End-use (Reference Laboratories, Point-of-care Testing/in-house Testing, Veterinary Hospitals & Clinics) & By Region - Forecast And Analysis 2020-2027
The Animal health market was valued at USD 50.89 Billion in 2020, and it is expected to reach a value of USD 99.51 Billion by 2027, at a CAGR of 8.8% over the forecast period (2020 - 2027).
The Animal healthcare industry is being driven by a large rise in worldwide protein food consumption, as well as an increase in the prevalence of zoonotic and food-borne illnesses. As a result of the exponential rise in illness prevalence, companies have been driven to create novel vaccines and medicines. As a consequence of the increasing demand, the number of firms making constant efforts to manage pathogen contamination concerns and food-borne illnesses has increased, contributing to market growth.
Furthermore, the growing number of government initiatives to promote animal health products is likely to have an impact on total demand. Increased production of animal-based food items would result in significant price reductions, making healthy food more readily available. The business is also being driven by technological advancements in veterinary health care, which is projected to create new development prospects.
This report provides in-depth analysis of Global Animal health market. We have analyzed 20+ data points that include product price trends, consumer purchase patterns, company annual sales performance, COVID-19 impact on distribution channels, parent industry performance, regional trends, and technological innovations, for tracking the Global market size and performance in the recent years.
Global Animal Health Market Segmentation
The Global Animal health market is segmented based on Type, Product, Distribution Channel, End-use, and Region. Based on Type it is categorized into: Production Animal, Poultry, Swine, Cattle, Sheep & Goats, Fish, Companion Animal, Dogs, Cats, Horses. Based on Product it is categorized into: Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Inactivated Vaccines, Pharmaceuticals, Parasiticides, Anti-infectives, Anti-inflammatory, Analgesics, Feed Additives, Nutritional, Medicinal, Diagnostics, Instruments, Consumables. Based on Distribution Channel it is categorized into: Retail, E-commerce, Veterinary Hospitals & Clinics. Based on End-use it is categorized into: Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics. Based on region it is categorized into: North America, Europe, Asia-Pacific, South America, and MEA.
Global Animal Health Market: Impact of COVID 19
The COVID-19 outbreak started in a meat market and has had a severe influence on animal-based food consumption. COVID-19 might only have a little influence on the animal health industry in a realistic situation. This scenario is expected to have a major influence on the main end-user category for animal welfare, veterinary hospitals and clinics, livestock farming, and homecare situations. This might be due to a lack of trade and transportation regulations, which are expected to gradually increase in 2020 when most nations' trade connections return to a more normal level..
Key Trends in Global Animal Health Market
Because of the potential of foodborne illnesses in the United States, traction for farm animals is expected to boost the trend for healthcare. More crucially, the penetration of livestock animals in North America has been driven by vigorous stakeholder activities and an increase in human consumption. It's worth noting that the rising demand for vaccinations, medicines and medicated feed additives has prompted an expansion of the pharmaceutical portfolio. Investment in the pharmaceutical industry is expected to rise in the next five years due to an increase in the number of pet animals and an increased risk of infection.
Forward-thinking businesses have increased their efforts to offer companion animal healthcare services and products. Adoption of dogs, cats, and horses, in particular, has increased in recent years in the United States and Canada, indicating a promising future—the companion animal category was valued at over US$35,000 million in 2019. The Veterinary Services Directorate in the United States seeks to develop an animal health system and provide animal health services to improve livestock productivity and efficiency.
Global Animal Health Market: Regional Dynamics
Because of the vast range of decisive measures implemented by various government animal welfare groups that are constantly striving for overall improvement in animal health, North America gained the largest revenue share of the global market of over 32% in 2020. Furthermore, technological advances, an increase in the number of pet owners, and the increased prevalence of zoonotic illnesses are projected to drive market expansion in this area. The regional market is expected to be driven by several joint initiatives by big firms to improve their R&D skills and assure high-quality standards. Furthermore, the largest portion can be attributable to the disease burden in this region.
Global Animal Health Market: Competitive Landscape
The market is characterized by the presence of a few well-established players. New product launches, partnerships and investing in research & development have been a key business strategy. Some of their recent developments are as follows:
In December 2020, Neogen Corporation will debut its new Igenity Canine Wellness, a preventative care DNA screening tool for veterinarians. Such innovations will aid the company's expansion in the field of animal genetic testing.
In July 2020, Fish Vet Group, a business that develops and commercializes fish vaccines as well as diagnostics and immunization services for aquaculture, was purchased by Zoetis. This purchase allowed Zoetis to broaden its global reach and strengthen its testing and diagnostics capabilities in key aquaculture markets across the world.
In November 2018, Merck Animal Health introduced the INNOVAX-ND-IBD, the first live poultry vaccine in the United States. It protects against three highly contagious illnesses in chickens: Marek's disease (MD), Newcastle Disease (ND), and Infectious Bursal Disease (IBD). The development of this medication aided the firm in combating many untreated chicken illnesses in the United States.
Key players in Animal health market are:
Merck Animal Health
Ceva Santé Animale
Boehringer Ingelheim GmbH
Scope of the Report
The study provides an analysis of the Global Animal health Market in the emerging and established markets across the globe, including North America, Europe, Asia-Pacific, South America, and Middle East & Africa. For each segment, the market sizing and forecasts have been done on the basis of value.